logo
‘Fat jabs left me so depressed it was like having The Deer Hunter theme on repeat in my head'

‘Fat jabs left me so depressed it was like having The Deer Hunter theme on repeat in my head'

Telegrapha day ago
I can say without any doubt that I've never been depressed. So when I began using weight-loss injections three months ago it was a huge shock to find that rather than my usual unhappy-go-lucky self, I sensed something new. Something really bad. I was depressed and I could only assume it was a side effect of the drugs.
Within a week of my first injection I felt a deep despair, seemingly from nowhere. Nothing had happened in my work or social life to trigger it. For a few days I searched for a cause, confused and concerned about where this blackness had come from. Suddenly, to an almost absurd, comical extent, existence seemed bleak and irredeemable. It was like having the theme tune to 1978's war drama The Deer Hunter playing in my head on repeat.
After the initial shock, I had to somehow find a way to recognise this state for what it was: artificially induced – the mental equivalent of fake news.
I have known lots of people with 'real' depression: the kind that keeps a person in bed for a week as if there were a weight tied to their body. The kind that waxes and wanes without reason, making it hard for those around them to empathise. I'd never known that feeling, yet here it was squatting on top of me day after day.
Using weight-loss injections produced no other side effects. I have been sleeping well, I've not felt any nausea and I have undoubtedly lost weight, which was the whole point of this expensive experiment in the first place.
Much of what has been written about the mental health impact of these treatments has been on either the positive effects of losing weight – improved self esteem – and how some who experience ADHD report a heightened sense of focus and concentration.
Nowhere in the literature of the companies that make the treatments, or those who sell it, is there any suggestion that depression is a verifiable risk. Side effects are listed as nausea and vomiting, constipation, diarrhaea, reflux, headaches and fatigue. So much the same as a long stag weekend, rather than a continuous vigil at the edge of the abyss.
The medications in question are known as 'glucagon-like peptide-1 receptor agonists' (examples are semaglutide in Ozempic and Wegovy, and tirzepatide in Mounjaro). They were conceived as a treatment for diabetes and were later found to have beneficial effects fighting obesity. They may also help with cardiovascular disease and even neurological disorders such as Alzheimer's. They work by mimicking the effects of the hormone GLP-1, which helps regulate blood sugar levels and appetite.
Dr Riccardo De Giorgi, Clinical Lecturer in General Adult Psychiatry at the University of Oxford is currently studying the effects of these drugs and admits that it is too soon to know if there is a possible link with depression, but suggests evidence points to a positive, rather negative, impact on mental health.
'The most recent studies available suggest that GLP-1 medications do not increase depressive symptoms or suicidality,' he says. 'These are based on drug trials where the patients were measured for depression 'scores' and psychological wellbeing, and they didn't show a negative effect overall.
'What happens if you are exposed to these drugs and you have a history of depressive episodes? In that regard, we don't have any evidence at all. There are now some more trials pending on depression, but it's very early days.'
I asked around amongst friends and friends of friends (there are so many people using these treatments now that they aren't hard to find), and several reported very similar experiences to my own. One mentioned feeling 'oversensitive and on the verge of tears all the time'. Another said she felt so depressed and exhausted through emotional stress that she had to stop using it. She wanted to start using jabs again but was afraid of reliving her depression. A third said the worst days were 'shocking' but eventually she began to feel better – whether that was because the effects wore off or because she became more adept at coping she couldn't be sure.
For me, the strangest feature of this self-inflicted ordeal was that I couldn't trust my emotions. It was like I was in my own matrix, where what I was experiencing felt real but was actually a simulation I had brought on myself – all while paying a monthly fee for the privilege.
When something bothered me at work, there was no way to measure its real importance, which meant there was no reliable way to respond to it. How could I tell if a crisis at home was trivial, a total catastrophe or something in between? Thinking about the terrible state of Britain and the world suddenly felt deeply personal rather than an essential part of my job. Just hearing the first bars of a John Barry film score or recalling a random memory of my daughters set me off like Adele at an awards ceremony.
I wondered if my new mood was connected to missing food, since I had become a one-meal a day person with no snacking. Maybe giving up eating for pleasure was getting me down? But while I love food like Keir Starmer loves free glasses, not even giving up crisps could make me feel this hopeless.
The accepted routes for treating 'real' depression do not really apply to me since all I needed to do was stop the injections. I could hardly start taking anti-depressants to cope with the artificially induced depression brought on by other drugs.
Therapy to treat it also seemed ridiculous, since it would be treating something that I had the power to stop. That was not a luxury afforded to those unlucky enough to experience the real thing. The therapists I asked about this were none the wiser, expressing confusion about how they might treat a patient who believed their depression had been triggered not by a pre-existing condition or circumstance, but by weight-loss injections. For me, feeling this way was my choice: a trade off for a thinner waist and a current drop of 1st 9lbs.
Dr De Giorgi offered one explanation, yet admits that until he and others are able to conclude further research there is still no clinical evidence of a link between the drugs and depression.
'Some forms of depression are associated with high levels of inflammatory molecules, in which case the anti-inflammatory effects of GLP-1 medications would be helpful,' he explains. 'For other people, who are less prone to inflammation, the drugs might upset the balance in the body that is already in a sweet spot, so the drugs mean you have 'too little inflammation'. A degree of healthy inflammation is needed for the normal upkeep of brain cells. GLP-1 medications seem to be able to enter the brain, so we shouldn't be surprised if we find there are other implications such as mental effects.'
Even if a link was ever proven, which is not likely as things stand, it's hardly going to provide much comfort. Most recently, the icing on this doom-laden cake – the kind a goth would get for his birthday at a Dracula festival in Whitby – was that I began to have nightmares. A mixture of Franz Kafka's brand of horror and Stephen King's It, they were like video nasties in which the lead character shouts: 'This isn't real!' and tries to wake themselves up. After a couple of these, I had to set a deadline to get myself off this stuff. No chiselled jawline is worth this. Kate Moss once famously said: 'Nothing tastes as good as skinny feels', but, for me, it was a case of nothing feels as bad as skinny tastes.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘Functional beverages' are booming — but is it all hype?
‘Functional beverages' are booming — but is it all hype?

Times

time3 hours ago

  • Times

‘Functional beverages' are booming — but is it all hype?

Before you take that magnesium supplement or sit down to meditate, what if a drink could help you relax? Enter 'functional beverages', drinks that claim to possess additional health benefits beyond those of a standard fizzy drink or fruit juice. Functional drinks are surging in popularity, with supermarkets in Britain seeing sales increase by 24.5 per cent in the past year, according to Worldpanel by Numerator. The market research firm also said that almost 30 per cent of UK households now purchase functional drinks. However, Nichola Ludlam-Raine, a dietician with more than 15 years of clinical experience in the NHS, has warned that she 'wouldn't rely on them [functional drinks] for measurable health benefits'. Ludlam-Raine, who now works privately and is the author of How Not to Eat Ultra-Processed , said: 'Functional drinks containing ingredients like CBD [cannabidiol], lion's mane [a type of mushroom], and ashwagandha [a herb typically used in ayurvedic medicine] are part of a growing wellness trend, but the science isn't as strong as the marketing.'

NFL star heading to Philadelphia Eagles in bombshell trade after overcoming leukemia battle
NFL star heading to Philadelphia Eagles in bombshell trade after overcoming leukemia battle

Daily Mail​

time5 hours ago

  • Daily Mail​

NFL star heading to Philadelphia Eagles in bombshell trade after overcoming leukemia battle

The Philadelphia Eagles are acquiring wide receiver John Metchie III from the Houston Texans, according to multiple reports. Metchie, a four-year veteran of the league, will be playing in only his third year of action after sitting out his rookie season. After being selected in the second round of the 2022 NFL Draft, Metchie was diagnosed with acute promyelocytic leukemia. He missed the entire campaign as he underwent treatment.

Obese to get soups and shakes diet instead of weight-loss jabs
Obese to get soups and shakes diet instead of weight-loss jabs

Times

time6 hours ago

  • Times

Obese to get soups and shakes diet instead of weight-loss jabs

Low-calorie soups and shakes are to be prescribed to thousands of overweight people in Scotland in an attempt to reduce their dependence on expensive weight-loss drugs and provide longer-lasting health benefits. From January, 3,000 patients who have been newly diagnosed with type 2 diabetes will be recruited for a clinical trial. About 300,000 Scots live with type 2 diabetes, a condition commonly linked to obesity, in which badly regulated blood sugar levels can increase the risk of heart disease, kidney disease, strokes or nerve conditions. About 10,000 of them are being treated with weight-loss drugs such as Ozempic, Wegovy and Mounjaro, with injections costing the NHS £3,000 a year. The estimated annual bill of £30 million is expected to rise as manufacturers raise prices. NHS chiefs believe that not only will the soups and shakes plan be less expensive, it will also bring longer-term health benefits. In the Total Diet Replacement (TDR) plan, to be rolled out over three years, patients who have recently been diagnosed with type 2 diabetes and are deemed eligible will be given low-calorie substitutes for their breakfast, lunch and dinner. The replacement meals, containing a maximum of 900 calories a day, will be delivered to patients for between three and five months. • What to do now Mounjaro's hiking its prices, by an obesity expert After this initial period, normal food will be reintroduced, but with guidance given on healthy meals through online consultations and an app. The ambition is for patients to lose up to 10 per cent of their body weight over a year. Doctors are also optimistic that up to 40 per cent of the trial participants will achieve remission from type 2 diabetes within a year. There are fears that the weight lost through injections — which work by suppressing the appetite — may last only as long as the patient is taking the drug. By contrast, the effects of diet changes should prove more long-lasting and cost effective, NHS officials believe. The TDR scheme is set to cost £5.6 million for 3,000 patients, a one-off cost of about £1,866 per person. Doctors hope the plan will help patients to fundamentally alter their diet and lifestyle. A spokesman for the Scottish government said: 'We anticipate that around 35 to 40 per cent will achieve remission from type 2 diabetes at the end of their first year on the programme, with a majority of patients benefiting from a clinically significant average weight loss of 10 per cent.' This would lead to reductions in blood pressure and contribute to a reduced risk of cardiovascular disease. He added: 'We will measure impact by the number of patients recruited into this programme, the number who achieve remission and the number with clinically significant weight loss.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store